获得更多客户是一个结果。决策在于选择哪条路径你能负担得起重复使用。 对 B2B SaaS 公司来说，这出现在特定位置。承载答案的数字是净收入留存率和 CAC 回本期，而该行业特有的复杂之处在于增长率从 42% 降至 32%，同时 60% 的收入集中在经济效益最差的细分领域。一般版本的问题和你实际面对的问题，首次行动不同。
获得更多客户是一个结果。决策在于选择哪条路径你能负担得起重复使用。 对 B2B SaaS 公司来说，这出现在特定位置。承载答案的数字是净收入留存率和 CAC 回本期，而该行业特有的复杂之处在于增长率从 42% 降至 32%，同时 60% 的收入集中在经济效益最差的细分领域。一般版本的问题和你实际面对的问题，首次行动不同。
几乎每家企业都能列出几种获取客户的方法，但很少能说出哪一种能回本。这才是真正的约束：不是缺少策略，而是缺乏关于该多做哪种策略的证据。
有效的框架是路径经济学。对于每条可能的路径——外呼、转介、合作伙伴、搜索、活动、渠道——获取一个客户的成本是多少，多久能回本，以及能否在规模化时不增加成本地重复。
大多数路径通不过第三项测试。它们在小规模时有效，因为依赖创始人的网络或注意力，一旦耗尽就悄然失效。
这三者同时出现才是标志。单独一个通常指向其他问题。
✓ 增长依赖于一个人的关系
✓ 单个客户的成本未知或仅以汇总形式知晓
✓ 每个渠道都在小规模尝试，但没有一个得到充分测试
通常会让情况更糟的做法。 同时以低于规模的水平运行多个渠道，这不会对任何渠道产生明确结果，且成本高于正确测试一个渠道。
It is for you if you run or finance a B2B SaaS company and growth depends on one person's relationships. It is the situation where the numbers are available but nobody has put them in an order that produces a decision.
It is not for you if Percision is the wrong tool if you already know the answer and only need execution capacity, or if the business is pre-revenue — then the constraint is evidence about the market, not analysis of your own figures. Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library. Also wrong if you need facilitation, politics, or someone to sit with a lender or buyer. Those are human jobs.
Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library.
Below is an excerpt from a real run of this analysis on 一家 B2B SaaS 公司. It is a sample profile rather than a customer, and it is engine output translated from English — this is the format you get, on your own numbers.
The subject is TechNova Solutions, a sample company profile used for testing rather than a customer — $45M ARR, 280 engineers.
Excerpt from a real Percision run · Quick Market Scan · sample company profile
The move. Turn the 11-week implementation backlog into 50 reusable modules that lift services gross margin from 41 % to 55 % while preserving 23 % win rate.
| Investment required | $3.0-4.2 M total over 36 months |
| Expected return | Base case 3.8× cash-on-cash within 36 months |
| Revenue, year 1 | $47.8-49.2 M ARR |
| Revenue, year 2 | $51.5-54.0 M ARR |
| Revenue, year 3 | $56.0-60.0 M ARR |
| Exit criteria | Strategy abandoned if, by Month 12, template-able rule rate remains below 40 % OR if NRR of pilot cohort falls below 85 %; capital reallocated to Segment 2 analytics bolt-on. |
This is one move out of a full analysis. Read a complete report — every page, no email required.
This question routes to Go-to-Market 与商业策略, one of 29 engagements the platform runs. For B2B SaaS 公司 it works through net revenue retention, CAC payback, ACV by segment and gross margin, then produces the sequence rather than a list of options — which move first, what it funds, and the observation that would say the sequence is wrong.
You watch the analysis get built before paying anything. 在此阅读完整报告 if you would rather see the depth first.
你的买家已经在的、且你能在可融资的周期内回本获客成本的渠道。这是业务特定的，通用答案价值很小。
先运行一个有效的，然后再运行第二个。以四分之一必要预算运行四个渠道，通常会产生四个不确定的结果，并让人相信什么都不起作用。
你的销售周期加上一个回本期，以及足够区分结果与噪音的量。在事前设定这个数字，能防止决策被最有说服力的人左右。
Materially, yes. Growth has fallen from 42% to 32% while 60% of revenue sits in the segment with the worst economics — which changes both the diagnosis and the order of the fixes. The metrics that decide it here are net revenue retention, CAC payback, ACV by segment, and an answer built on industry-general benchmarks will usually point at the wrong one first.
Less than most people expect. Your last twelve months of revenue and cost split the way you already split it, plus whatever you hold on net revenue retention and CAC payback. The analysis is explicit about what it is assuming where your data stops, which is more useful than waiting for numbers you may never have.
Percision is the wrong tool if you already know the answer and only need execution capacity, or if the business is pre-revenue — then the constraint is evidence about the market, not analysis of your own figures. Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library. Also wrong if you need facilitation, politics, or someone to sit with a lender or buyer. Those are human jobs.
Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library.
Describe the situation in your own words and we will tell you which analysis answers it — before you sign up for anything.
Describe my situation →Prefer to skip ahead? Go straight to the free diagnostic.
English · Español · Deutsch · Português · Français · Italiano · Nederlands · 日本語 · 한국어 · 中文 · Polski · Svenska · Türkçe · العربية · Tiếng Việt · ไทย · हिन्दी · עברית